What are the most common mistakes with AOD-9604?
The most common AOD-9604 mistakes are expecting GLP-class results (it isn't that potent); dosing post-meal (blunts the fat-mobilization effect); running it without diet alignment. Most issues people run into come down to protocol and expectations, not the compound itself. Going in informed matters here because human evidence for AOD-9604 is limited.
Common AOD-9604 mistakes
- Expecting GLP-class results (it isn't that potent)
- Dosing post-meal (blunts the fat-mobilization effect)
- Running it without diet alignment
References
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone — Ng FM, Sun J, Sharma L, et al., Hormone Research, 2000
- The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice — Heffernan M, Summers RJ, Thorburn A, et al., Endocrinology, 2001
- Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans — Stier H, Vos E, Kenley D, Journal of Endocrinology and Metabolism, 2013;3(1-2):7-15
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on AOD-9604
Last updated 2026-06-15.